Get a pulse on US healthcare with medical and pharmacy claims data

Predict earnings surprises, track drug adoption and sales, measure label expansion, and analyze market access based on domestic pharmacy and medical claims data. Available exclusively for investors.

A man and a woman working together and looking at a computer

Trusted by thousands of investors and business leaders

“Earnest’s suite of healthcare claims datasets represent the most complete view of medical trends available in the market. With best-in-class latency and large sample size, there is no better way to track everything from patient journeys to drug adoption.”

Julia Fitzgerald

Director of Healthcare Products

Access Earnest data on

Google Cloud Platform

Amazon S3

Tableau

Earnest Dash

Demystify biotech investing with US healthcare data

Request more information

5

Health insurance claims datasets

Tap into the industry leading health insurance claims database with multiple healthcare claims datasets including both pharmacy claims data and medical claims data.

4000+

Drugs, devices, and therapies

Get devices, therapies, and rx claims data after it has been cleaned and structured for analysis, so you can focus on your thesis, not ingestion.

900,000

Physicians

See claims filed by a diverse array of health professionals giving insight into indication, market access, and utilization.

3

Sources

Leverage data from two major US healthcare claims clearinghouses, as well as a national health services company.

Your one-stop-shop for claims data in healthcare investing

Request more information

Predict revenue surprises

Track correlations between medical and pharma claims data and company reported metrics, anticipating earnings surprises before they happen.

Track patient journeys and persistence

See how long users use a device or drug after first use. Then track possible switching as competing therapies come to market.

See specialty and retail drug utilization

Use specialty pharmacy claims data to see drug and marketing program utilization, including manufacturer bridge programs.

Monitor infusion therapeutic and medical procedure/device utilization

Stay up-to-date on device utilization rates for emerging devices and infusion therapeutics in near real-time.

See Healthcare Claims data in action

Earnest Analytics partnered with the BMO Capital Markets’ BioPharma team to add insight into GLP1 therapeutic usage.

Read the case study